Edition:
India

Caplin Point Laboratories Ltd (CAPL.NS)

CAPL.NS on National Stock Exchange of India

620.90INR
2:15pm IST
Change (% chg)

Rs-6.55 (-1.04%)
Prev Close
Rs627.45
Open
Rs627.50
Day's High
Rs648.00
Day's Low
Rs618.00
Volume
37,413
Avg. Vol
62,317
52-wk High
Rs784.80
52-wk Low
Rs335.00

Chart for

About

Caplin Point Laboratories Limited is a pharmaceutical company. The Company's product segments include Antibiotics, Non-steroidal anti-inflammatory drugs (NSAIDS), Ophthalmics, Pain Management and Anti-ulcers. The Company offers a range of products, including Tablets, Liquid Orals, Capsule, Softgel Capsules, Suppositories and... (more)

Overall

Beta: 1.63
Market Cap(Mil.): Rs53,659.49
Shares Outstanding(Mil.): 75.58
Dividend: 1.50
Yield (%): 0.21

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-India's Caplin Point Laboratories Sept-qtr consol profit rises

* Sept quarter consol profit 355.7 million rupees versus profit of 224.1 million rupees year ago

09 Nov 2017

BRIEF-Caplin Point Laboratories gets U.S. FDA approval for ketorolac tromethamine injection

* Says gets FDA approval for ketorolac tromethamine injection 30 mg/ml in U.S.

20 Sep 2017

BRIEF-Caplin Point Labs approves re-appointment of Sridhar Ganesan as MD‍​

* Says approved re-appointment of Sridhar Ganesan as MD‍​ Source text for Eikon: Further company coverage:

07 Aug 2017

BRIEF-India's Caplin Point Laboratories June-qtr consol profit rises

* June quarter consol profit 363.2 million rupees versus profit 159.8 million rupees year ago

07 Aug 2017

Earnings vs. Estimates